RECORDATI |
Market Closed -
Other stock markets
|
After market 19:04:42 | |||
| 50.35 EUR | -1.66% |
|
50.38 | +0.05% |
| 05:46pm | Mib up, Nexi and Prysmian good after accounts | AN |
| 05:12pm | Recordati initiates buyback for maximum EUR85 million | AN |
This article is for Premium subscribers only
Signed up already?
Log InNot subscribed yet?
Subscribe
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
Pharmaceuticals
Calendar
08/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
51.2
EUR
Average target price
52.14
EUR
Spread / Average Target
+1.84%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.11% | 11.33B | |
| +32.85% | 698B | |
| +26.51% | 568B | |
| -4.57% | 358B | |
| +19.34% | 328B | |
| +3.61% | 283B | |
| +16.34% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +8.78% | 165B |
- Stock Market
- Equities
- REC Stock
- News Recordati
- Recordati: An Italian mid-cap that has everything going for it
